MSC Nanomedicine is a Masters program taught at University of Manchester, UK. The program is offered in campus-based modes with full-time (12 months full-time) options.
The University of Manchester’s MSc Nanomedicine gives an in-depth understanding of nanomedicine, the biological effects of nanomaterials, and therapeutic applications. The course covers the role of nanomedicine within healthcare innovation, including interactions with biological systems, delivery of therapeutics (including COVID-19 vaccine and cancer therapies), biomarker discovery, bioimaging, and the treatment of neurodegenerative diseases.
Delivered as a 12 months full-time programme in person, the MSc includes a 25-week lab-based research project to develop research skills. The course prepares students for a PhD, specialist clinical training, or careers in nanotoxicology, nanomedicine, pharmaceuticals, or biotechnology.
The minimum requirements for admission in MSC Nanomedicine at University of Manchester for all applicants (Domestic or International) are:
Note: Please check the university website in the link below.
We require a minimum of an Upper Second class honours degree (or overseas equivalent) in: biological sciences; biomedical sciences; pharmacy; medical sciences; materials sciences; biomedical materials; bio/chemical engineering; chemistry.
This course is also available for intercalating medical students, both from The University of Manchester and other UK universities. Minimal requirement for admission will be satisfactory achievement in Years 1-3 of the undergraduate medical programme.
International students must demonstrate English proficiency at the point of application through a secure and approved testing system. Specifically, we require a minimum of:
Please check detail of study units at https://www.manchester.ac.uk/study/masters/courses/list/21719/msc-nanomedicine
85 fully funded scholarships are listed for UK. See UK scholarships.